DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click
HERE to register or log in.
Accession Number:
AD1046526
Title:
Combination Therapies for the Mitigation of Musculoskeletal Pathologic Damage in a Novel Model of Severe Injury and Disuse
Corporate Author:
University of Texas Southwesern Medical Center Dallas United States
Report Date:
2017-10-01
Abstract:
Severe injury in patients results in adverse physiologic and musculoskeletal changes that are immediate and long lasting. In response to injury, metabolic and physiologic responses determine length of hospitalization and subsequent activity limitations. Reduced mobility from bed rest and injury severity affect muscle and bone health and are detrimental to rehabilitative success. Therefore, means to counteract adverse effects on muscle and bone after injury and disuse are needed. Pharmacologic i.e insulin or oxandrolone, non-pharmacologic i.e. exercise and nutritional interventions have been used independently with limited success 17. The combination of pharmacological interventions and exercise has not been systematically investigated. We propose to determine if the administration of pharmacologic agents combined with exercise attenuates muscle atrophy and bone degradation following severe injury, disuse and re-ambulation. The current proposal is for mitigation of musculoskeletal pathologic change in polytrauma patients.
Descriptive Note:
Technical Report,30 Sep 2016,29 Sep 2017
Pages:
0034
Distribution Statement:
Approved For Public Release;
File Size:
1.40MB
